The Latest Breaking News on Pharma

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring

We need to consider a vaccine strategy that will provide longer-term immunity

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

An Australian-first clinical trial for a new needle-free COVID-19 vaccine has begun on the Sunshine Coast, in good news for those who fear the jab.

Chief financial officer David Denton reportedly told investors at the drug maker that he expects profits will continue to rise

Research suggests the drug, called Evusheld, would be 88% effective at preventing intensive care admission for people with weakened immune systems still shielding from Covid because vaccines don't work for them.

SAN JOSE, Calif. — Bay Area tech and biotech companies have recently revealed plans to chop thousands of jobs, layoffs that raise the specter that these cutbacks might haunt the region’s broader economy.

Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.

Active ingredient of magic mushrooms still classified as having no medical value, despite clinical success

The World Health Organisation (WHO) has said these are filling the gaps where Omicron was once rampant